Undecimal Bio funding
Cambridge-based Undecimal Bio, a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics, today announced a €16 million ($18 million) Seed financing round to expand DELiveri, its proprietary AI-enabled platform f Headquarters: .
Funding rounds
- Undecimal Bio raises $19M Seed, . AI apps. Cambridge-based Undecimal Bio, a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics, today announced a €16 million ($18 million) Seed financing round to expand DELiveri, its proprietary AI-enabled platform f
Questions
How much has Undecimal Bio raised?
Undecimal Bio has raised $19M in the 1 round Funding tracks, most recently a Seed announced Oct 13, 2026.
What is Undecimal Bio's valuation?
No valuation has been reported for Undecimal Bio's tracked rounds.
Who invests in Undecimal Bio?
The investors were not disclosed.